Stock Market & Financial Investment News

News Breaks February 26, 2013 18:02 EDT QCOR Questcor reports Q4 non-GAAP EPS $1.09, consensus $1.03 Reports Q4 revenue $160.5M, consensus $142.58M. The company said net sales increased primarily due to expanded prescribing of H.P. Acthar Gel by nephrologists in the treatment of nephrotic syndrome, as well as continued prescribing by neurologists in the treatment of MS relapses and infantile spasms. Net sales also benefitted from the initiation of commercial activities focused on the use of Acthar by rheumatologists in the treatment of on-label rheumatology-related conditions. News For QCOR From The Last 14 Days Check below for free stories on QCOR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 11:20 EDT QCOR Options with increasing implied volatility: QCOR MYGN GDI Subscribe for More Information 05:57 EDT QCOR Stocks with implied volatility movement; SODA QCOR Subscribe for More Information May 7, 2013 12:53 EDT QCOR Options with decreasing implied volatility: QCOR BMC FOSL TPX LNKD Subscribe for More Information 05:55 EDT QCOR Stocks with implied volatility movement; QCOR GRPN Stocks with implied volatility movement; Questcor (QCOR), Groupon (GRPN) according to iVolatility. May 6, 2013 12:00 EDT QCOR Options with decreasing implied volatility: RVBD UNXL FIRE QCOR EBIX Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.